Frontier Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,500
Closed -$507K 280
2020
Q1
$507K Sell
2,500
-1,200
-32% -$262K 0.04% 138
2019
Q4
$892K Buy
3,700
+500
+16% +$110K 0.05% 124
2019
Q3
$619K Buy
+3,200
New +$614K 0.04% 138
2019
Q2
Sell
-2,500
Closed -$475K 274
2019
Q1
$475K Hold
2,500
0.03% 170
2018
Q4
$487K Sell
2,500
-500
-17% -$97.5K 0.04% 165
2018
Q3
$622K Hold
3,000
0.04% 161
2018
Q2
$554K Buy
+3,000
New +$531K 0.04% 158

Other funds holding AMGN

Frontier Investment Management's AMGN Position: Q2 2020 in Review

Frontier Investment Management reduced its Amgen (AMGN) stake by 9.3% in Q2 2020, selling an estimated $65K and leaving 2,775 shares worth $654K. The position accounts for 0.04% of the portfolio, ranked #136.

Frontier Investment Management first reported a position in AMGN in Q2 2013 and has held it in 29 quarters since. The position peaked at $4.79M in Q3 2016. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • Frontier Investment Management held 2,775 shares of Amgen worth $654K as of Q2 2020.
  • Frontier Investment Management sold 285 Amgen shares in Q2 2020, an estimated $65K.
  • Amgen made up 0.04% of Frontier Investment Management's portfolio in Q2 2020, its #136 holding.
  • Frontier Investment Management first reported a position in Amgen in Q2 2013 and has held it in 29 quarters since.
  • Frontier Investment Management's Amgen position peaked at $4.79M in Q3 2016.
  • 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.